

28 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/currax-pharmaceuticals-to-spotlight-new-research-at-obesityweek-2025-highlighting-craving-control-behavioral-adherence-and-subpopulation-outcomes-with-contrave-302596289.html

21 Sep 2017
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207389

24 Aug 2017
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208652